` Comparison: 286A vs CGN - Alpha Spread

286A
vs
C
CGN

Over the past 12 months, 286A has outperformed CGN, delivering a return of -10% compared to the CGN's 21% drop.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
286A
CGN
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

286A Intrinsic Value
HIDDEN
Show
CGN Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
EUCALIA Inc
TSE:286A
872 JPY
C
Cigna Group
XMUN:CGN
232.85 EUR
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
286A, CGN

286A
CGN
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
EUCALIA Inc
Revenue
C
Cigna Group
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
286A, CGN

286A
CGN
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
EUCALIA Inc
TSE:286A
C
Cigna Group
XMUN:CGN
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

286A
42.6%
CGN
9.3%
LTM 3Y Avg 5Y Avg 10Y Avg
EUCALIA Inc
C
Cigna Group

Operating Margin

286A
9.6%
CGN
3.7%
LTM 3Y Avg 5Y Avg 10Y Avg
EUCALIA Inc
C
Cigna Group

Net Margin

286A
11.2%
CGN
2.2%
LTM 3Y Avg 5Y Avg 10Y Avg
EUCALIA Inc
C
Cigna Group

FCF Margin

286A
-10.3%
CGN
3.1%
LTM 3Y Avg 5Y Avg 10Y Avg
EUCALIA Inc
C
Cigna Group

ROE

286A
14.4%
CGN
14.4%
LTM 3Y Avg 5Y Avg 10Y Avg
EUCALIA Inc
C
Cigna Group

ROA

286A
4.4%
CGN
3.8%
LTM 3Y Avg 5Y Avg 10Y Avg
EUCALIA Inc
C
Cigna Group

ROIC

286A
4.4%
CGN
6%
LTM 3Y Avg 5Y Avg 10Y Avg
EUCALIA Inc
C
Cigna Group

ROCE

286A
4.7%
CGN
10.3%
LTM 3Y Avg 5Y Avg 10Y Avg
EUCALIA Inc
C
Cigna Group

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
286A, CGN

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
286A, CGN

Performance Gap Between 286A and CGN
HIDDEN
Show

Performance By Year
286A, CGN

Loading
286A
CGN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 286A to other stocks
CVS
CVS Health Corp
Cheaper
vs 286A
CI
Cigna Corp
Cheaper
vs 286A
FRE
Fresenius SE & Co KGaA
Cheaper
vs 286A
FME
Fresenius Medical Care AG
Cheaper
vs 286A
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett